Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 7/20 | 0.53 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7068718 | 0.94 | MAOA (0.51) | MAOAMAOBHRH3 | |
| SCHEMBL7121486 | 0.86 | — | — | |
| SCHEMBL8169120 | 0.78 | MAOA (0.53) | MAOAMAOB | |
| SCHEMBL7066688 | 0.78 | MAOA (0.53) | MAOAMAOB | |
| SCHEMBL11030664 | 0.78 | MAOA (0.53) | MAOAMAOBHRH3 | |
| SCHEMBL7235805 | 0.78 | MAOA (0.53) | MAOAMAOBHRH3 | |
| SCHEMBL1099184 | 0.78 | MAOA (0.53) | MAOAMAOBHRH3 | |
| SCHEMBL1099182 | 0.78 | MAOA (0.53) | MAOAMAOBHRH3 | |
| SCHEMBL1098438 | 0.78 | MAOA (0.53) | MAOAMAOBHRH3 | |
| SCHEMBL7363127 | 0.77 | MAOA (0.51) | MAOAMAOBHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003047585-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING BENZOFURANYL SUBSTITUTED 3-CYANOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SOLID TUMOURS | ASTRAZENECA AB (SE) | 2003-06-12 | — | — | WO | disclosed |
| WO-2003047584-A1 | QUINOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-06-12 | — | — | WO | disclosed |
| WO-2003047583-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING BENZOFURANYL SUBSTITUTED 3-CYANOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SOLID TUMOURS | ASTRAZENECA AB (SE) | 2003-06-12 | — | — | WO | disclosed |
| US-6515175-B2 | Impart oil and grease resistance to paper, and as oil proofing coatings on textiles, wood, masonry and the like | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-04 | — | — | US | disclosed |
| US-20020068802-A1 | Mono-and polyamides of perfluoroalkyl-substituted unsaturated acids | TYCO FIRE PRODUCTS LP | 2002-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068802-A1 | Mono-and polyamides of perfluoroalkyl-substituted unsaturated acids | FASN, CD68, FFAR1 | MAOA 265/4885MAOB 475/4885HRH3 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.